Galectin-3 Phosphorylation Is Required for Its Anti-apoptotic Function and Cell Cycle Arrest

This publication has 29 references indexed in Scilit:

• Galectin-3 Protects Human Breast Carcinoma Cells against Nitric Oxide-Induced Apoptosis
  The American Journal of Pathology, 2001
• Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
  International Journal of Cancer, 2000
• Galectin-3 Stimulates Cell Proliferation
  Experimental Cell Research, 1998
• Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3
  Gastroenterology, 1998
• Expression of galectin-3 modulates T-cell growth and apoptosis.
  Proceedings of the National Academy of Sciences, 1996
• Galectin-3 Is a Novel Substrate for Human Matrix Metalloproteinases-2 and -9
  Biochemistry, 1994
• Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2
  Nature, 1994
• BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
  Nature, 1994
• Evidence for the role of 34‐kDa galactoside‐binding lectin in transformation and metastasis
  International Journal of Cancer, 1990
• Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis
  Cancer and Metastasis Reviews, 1987